Results 211 to 220 of about 1,386,765 (307)

Onasemnogene Abeparvovec in Type I Spinal Muscular Atrophy: 24‐Month Follow‐Up From the Italian Registry

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Onasemnogene abeparvovec (OA) is an AAV9‐based gene therapy for spinal muscular atrophy type I (SMA I). Real‐world outcomes show increased response variability compared to clinical trials, and follow‐up data beyond 12–18 months are limited.
Marika Pane   +43 more
wiley   +1 more source

INFORMATIVE-COGNITIVE COMPONENT OF A PRE-TRIAL INVESTIGATION

open access: yes“International Humanitarian University Herald. Jurisprudence”, 2020
openaire   +1 more source

Botulinum Toxin (Dysport) to Prevent Radiation-Induced Dysfunction of Salivary Glands in Head and Neck Cancer. [PDF]

open access: yesCancer Rep (Hoboken)
Farhan F   +12 more
europepmc   +1 more source

Quantifying the Impact of Ocrelizumab on Paramagnetic Rim Lesions in Multiple Sclerosis

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Paramagnetic rim lesions (PRLs) are a subset of chronic active multiple sclerosis (MS) lesions marked by iron‐laden microglia and macrophages. Ocrelizumab, a monoclonal antibody targeting CD20+ B cells, suppresses acute MS activity, but its effect on PRLs remains unclear. In a longitudinal study of 29 ocrelizumab‐treated patients with at least
Kimberly H. Markowitz   +9 more
wiley   +1 more source

On the issue of procedural management of pre-trial investigation

open access: yesBULLETIN of L.N. Gumilyov Eurasian National University. Law Series, 2019
B.Zh. Sagymbekov, R.S. Kaliaskarov
openaire   +2 more sources

SUSPENSION OF TIME LIMITS OF PRE-TRIAL INVESTIGATION

open access: yesScientific notes of Taurida National V.I. Vernadsky University. Series: Juridical Sciences, 2021
openaire   +1 more source

Reperfusion‐Dependent Outcomes After Endovascular Thrombectomy Stratified by NIHSS‐ASPECTS Clinical‐Core Mismatch

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective This analysis evaluates the effect of successful reperfusion on functional outcomes after MT, stratified by admission National Institutes of Health Stroke Scale (NIHSS) and Alberta Stroke Program Early CT Score (ASPECTS) as surrogates for clinical‐core mismatch, using multicenter registry data.
Felix Schlicht   +53 more
wiley   +1 more source

Home - About - Disclaimer - Privacy